Identification of two new mutations in congenital erythropoietic porphyria.
Congenital erythropoietic porphyria (CEP) or Günther's disease is an inborn error of heme biosynthesis transmitted as an autosomal recessive trait and characterized by a profound deficiency of uroporphyrinogen III synthase (UROIIIS) activity. Six missense mutations in the UROIIIS gene, a deletion and an insertion have already been described in CEP. This work brings further evidence for the heterogeneity in the genetic defect found in CEP. Two new mutations are described, a point mutation (V99A) and a frame-shift mutation (633insA) in the same patient who had a mild to moderate form of Günther's disease. The mutation (V99A) had a detectable residual activity when expressed in Escherichia coli while the insertion (633insA), which introduced a premature stop, had no activity. In the patients studied in our laboratory, the mutation C73R, associated with a severe phenotype, remains the most frequently seen.
Bensidhoum
M
M
Département de Biochimie médicale et Biologie moléculaire, Université de Bordeaux II, France.
Ged
C
C
Hombrados
I
I
Moreau-Gaudry
F
F
Hift
R S
RS
Meissner
P
P
Sturrock
E D
ED
de Verneuil
H
H
D001483:Base Sequence; D003001:Cloning, Molecular; D018388:Codon, Terminator; D018076:DNA, Complementary; D004912:Erythrocytes / Q000378:metabolism; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism; D016368:Frameshift Mutation; D006801:Humans; D008969:Molecular Sequence Data; D010641:Phenotype; D017354:Point Mutation; D017092:Porphyria, Erythropoietic / Q000235:genetics*; D011166:Porphyrins / Q000378:metabolism / Q000652:urine; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D015183:Restriction Mapping; D014576:Uroporphyrinogen III Synthetase / Q000235:genetics* / Q000378:metabolism
D018388:Codon, Terminator; D018076:DNA, Complementary; D011166:Porphyrins; D011993:Recombinant Fusion Proteins; D014576:Uroporphyrinogen III Synthetase